Gas-phase ambient air contaminants exhibit significant dioxin-like and estrogen-like activity in vitro.

Several adverse health effects, such as respiratory and cardiovascular morbidity, have been linked to exposure to particulate matter in ambient air; however, the biologic activity of gas-phase ambient organic air contaminants has not been examined as thoroughly. Using aryl hydrocarbon receptor (AHR)-based and estrogen receptor (ER)-based cell bioassay systems, we assessed the dioxin-like and estrogenic activities of gas-phase organic ambient air contaminants compared with those of particulate-phase contaminants using samples collected between seasons over 2 years from an urban and a rural location in the Greater Toronto Area, Canada. The concentration of the sum ([SIGMA]) of polycyclic aromatic hydrocarbons, which was highest in the gas phase, was 10-100 times more abundant than that of [SIGMA]polychlorinated biphenyls, [SIGMA]nitro-polycyclic aromatic hydrocarbons, and [SIGMA]organochlorine pesticides, and [10.sup.3] to [10.sup.4] times more abundant than [SIGMA]polychlorinated dibenzo-p-dioxins/dibenzofurans. Gas-phase samples induced significant AHR- and ER-dependent gene expression. The activity of the gas-phase samples was greater than that of the particulatephase samples in the estrogen assay and, in one case, in the AHR assay. We found no strong associations between either summer or winter seasons or urban or rural locations in the relative efficacy of the extracts in either the ER or AHR assay despite differences in chemical composition, concentrations, and abundance. Our results suggest that mechanistic studies of the health effects of ambient air must consider gas and particulate phases because chemicals present in both phases can affect AHR and ER signaling pathways. Key words: AHR, air pollution, CALUX, complex mixtures, endocrine disruption, ER, PAH. doi:10.1289/ehp.8496 available via http://dx.doi.org/[Online 29 December 2005]

**********

Adverse health effects in individuals of all ages have been linked to exposure to ambient air contaminants (American Academy of Pediatrics 2004; Jerrett et al. 2005; Pope et al. 2004a). Cardiovascular and respiratory morbidity and mortality are the most common health effects associated with exposure to ambient air contaminants, but other effects that have been linked epidemiologically include adverse fetal development (Dejmek et al. 2000; Liu et al. 2003; Perera et al. 2003) and cancer (Boffetta 2004; Cordier et al. 2004; Vineis et al. 2004). The actual mechanism by which these effects may be produced is frequently unclear, although a substantial body of work has elucidated the relationship between airborne particulate matter (PM) and vasoconstriction (Barclay et al. 2005; Brook et al. 2004; Pope et al. 2004b).

The possibility that ambient air contaminants may be involved in endocrine disruption is an intriguing question (Rogan and Ragan 2003). Several studies have demonstrated the ability of organic contaminants found in ambient air to activate intracellular receptors that are the entry points to signaling pathways implicated in endocrine disruption (Clemons et al. 1998; Vinggaard et al. 2000; Vondracek et al. 2004). In addition to epidemiologic studies that have demonstrated an association between exposure to ambient air contaminants and endocrine-disruptive effects (Jedrychowski et al. 2004; Perera et al. 2003, 2004), in vivo studies have shown reproductive effects in rodents exposed via inhalation to diesel exhaust (Furuta et al. 2004; Takeda et al. 2004; Watanabe and Kurita 2001).

Most toxicologic research examining ambient organic air contaminants has focused on contaminants sorbed to PM, yet the specific role that these organic contaminants may play in the biologic effects of ambient air contaminants remains unknown. A large fraction of many airborne chemical classes is present in part or almost exclusively in the gas phase, which has received little if any characterization for biologic activity.

In addition to the substantial challenge of determining the mechanisms underlying health effects from exposure to ambient air, it is important to recognize that not all of the potentially biologically active constituents of organic air contaminants have been isolated and identified. Urban air contains a complex mixture of constituents, of which only a small fraction has been identified (Rogge et al. 1993). Transformation products are rarely analyzed or considered in mass-balance analyses of the activity of organic extracts of ambient air contaminants in receptor-activation assays, even though they exhibit biologic activity (Fertuck et al. 2001; Machala et al. 2004; Wang et al. 2003). Further, exposure to these contaminants is variable and depends on such factors as the proximity to point or nonpoint sources, spatial and temporal variation, and atmospheric conditions.

To address the influence of spatial and temporal factors and to examine the potential biologic activity of the gas phase of organic contaminants in ambient air, we subjected extracts of particulate- and gas-phase ambient air samples, collected from both urban and rural locations in two seasons (winter and summer) over 2 years, to estrogen receptor (ER) chemically activated luciferase expression (CALUX) and aryl hydrocarbon receptor (AHR) CALUX cell bioassays. The CALUX assay is a rapid, sensitive, and well-validated method of assessing the capacity of either mixtures or single compounds to bind and activate the ER and AHR signaling pathways (Denison et al. 2004; Houtman et al. 2004; Rogers and Denison 2000). Previous studies have demonstrated that organic extracts of the particulate phase of ambient air contaminants are capable of activating these pathways in different in vitro assays, including CALUX (Hamers et al. 2000), but to our knowledge no study has yet examined the activity of gas-phase extracts.

Materials and Methods

Collection and preparation of air samples. Urban air samples were collected in downtown Toronto, Ontario, Canada, and rural air samples in Egbert, Ontario, Canada, 75-km northeast of Toronto. The downtown site was on the roof of a three-story building located on a heavily traveled street. The rural site was located at ground level at Environment Canada's Centre for Atmospheric Research. Samples were collected simultaneously at both sites for each sampling period. There were four sampling periods: 20-24 March 2000, 6-16 July 2000, 3-13 March 2001, and 31 July to 8 August 2001. Temperatures during the sampling periods were approximately 10[degrees]C for the winter (March) and 25[degrees]C for the summer (July-August). High-volume air samplers fitted with polyurethane foam plugs and Teflon filters were used to collect particulate-and gas-phase samples of ambient air. Samplers were run at a flow rate of approximately 1,000 [m.sup.3] per 24 hr. Samples were composited to represent the equivalent of approximately 8,000 [m.sup.3] of air taken over 5-10 days (in shorter sampling periods, two air samplers were deployed simultaneously).

Details of the extraction and cleanup of the air samples were reported previously by Dann (1998). Extracts were split, with 50% going to bioassays and 25% going to chemical analysis of polychlorinated dibenzo-p-dioxins/ dibenzofurans (PCDDs/PCDFs) and nitropolycydic aromatic hydrocarbons (N-PAHs), and 25% going to chemical analysis of PAHs, polychlorinated biphenyls (PCBs), and organochlorine (OC) pesticides. PAHs were quantified by capillary-column gas chromatography/ low-resolution mass spectrometry (GC/MS), whereas PCBs and OC pesticides were quantified by gas chromatography with electron capture detection (Harner et al. 2004). PCDDs/PCDFs and N-PAHs were quantified by high-resolution GC and high-resolution MS (Dann 1998). Concentrations were corrected for recoveries only for the PCDDs/PCDFs. Concentrations were not corrected for blanks because analyte concentrations in both method and field blanks were typically < 5% of those in the test samples.

Reporter cell lines. The AHR reporter cell line H1L6.1cl, a routine hepatoma cell line (Han et al. 2004), and the ER reporter cell line BG1Luc4[E.sub.2], a human ovarian carcinoma cell line (Rogers and Denison 2000), are stably transfected cell lines in which luciferase expression is regulated by AHR (H1L6.1c1) or ER (BG1Luc4[E.sub.2]). Cell lines were maintained as described previously by Hodge et al. (2003) and Rogers and Denison (2000).

Treatment of H1L6.1cl cells. Cells were plated at a density of 6 x [10.sup.4] cells/well in 12-well plates. After 24 hr, cells were treated with growth medium [[alpha]-minimal essential medium ([alpha]MEM) plus 10% fetal bovine serum (FBS); media control], growth medium plus 0.1% dimethyl sulfoxide (DMSO; solvent control), reference agonist [[10.sup.-7] M [beta]-naphthoflavone ([[beta]-NF)], or various dilutions of the air sample extracts. After 4 hr, the cells were lysed, and luciferase activity assessed as previously described (Garrison et al. 1996) using a commercially available luciferase assay (Promega, Madison, WI, USA). A 4-hr exposure was chosen to minimize any effect of cellular metabolism on the chemical composition of the extract (Windal et al. 2005). Luciferase activity was expressed as relative light units per milligram of cell lysate protein.

Treatment of BG1Luc4E2 cells. Cells were plated at a density of 6 x [10.sup.4] cells/well in 12-well plates. After 24 hr, the medium was changed to estrogen-reduced medium to minimize the basal expression of luciferase. Estrogen-reduced medium consisted of [alpha]MEM without phenol red (Gibco BRL, Burlington, ON, Canada) and 10% charcoal-stripped FBS (Hyclone Inc., Logan, UT, USA). After 48 hr, cells were treated with 17[beta]-estradiol ([E.sub.2])-reduced medium alone (media control), [E.sub.2]-reduced media plus 0.1% DMSO (solvent control), reference agonist ([10.sup.-10] M [E.sub.2]), or various dilutions of air sample extracts. At 72 hr, the cells were harvested and luciferase activity assessed as described (Rogers and Denison 2000).

Statistical analyses. In all cases, protein concentration was determined by the method of Bradford (1976). Curve fitting was performed using GraphPad Prism software (version 3.0; GraphPad Software, San Diego, CA, USA). Principal components analysis (PCA) was performed using SPSS version 11.0 (SPSS, Chicago, IL, USA).

Results and Discussion

Chemical analysis. The concentrations of the sum ([SIGMA]) of PCDDs/PCDFs ([SIGMA]PCDDs/ PCDFs; picograms per cubic meter of air), [SIGMA]PAHs (nanograms per cubic meter), [SIGMA] PCBs (nanograms per cubic meter), [SIGMA]N-PAHs (nanograms per cubic meter) and [SIGMA]OC pesticides (nanograms per cubic meter) in each of the 12 air samples are shown in Figure 1. The PAHs were the most abundant of all the chemical classes we analyzed and were present at concentrations [10.sup.3] to [10.sup.4] times greater than [SIGMA]PCDDs/PCDFs, and 10-100 times greater than [SIGMA]PCBs, [SIGMA]N-PAHs, and [SIGMA]OC pesticides. These concentrations are similar to those previously reported for other urban centers of North America and Western Europe (Currado and Harrad 2000; Dimashki et al. 2001 ; Lohmann et al. 2000).

[FIGURE 1 OMITTED]

As expected, concentrations of [SIGMA]PAHs, [SIGMA]PCDDs/PCDFs, [SIGMA]N-PAHs, and [SIGMA]PCBs in particulate- and gas-phase samples were higher in urban than in rural locations for July samples because of the geographic concentration of emission sources in the urban location. The absence of an urban-rural pattern in total OC pesticide concentrations may be explained by long-range transport of "legacy" pesticides long banned in North America [e.g., DDT (dichlorodiphenyltrichloroethane)] as well as agricultural activities and atmospheric transport of current-use pesticides such as endosulfan and lindane (Gingrich et al. 2001; Harner et al. 2004).

Concentrations of [SIGMA]PAHs and [SIGMA]PCDDs/ PCDFs were similar between March and July samples, indicating temporally consistent sources such as mobile and stationary combustion (Lee et al. 2003). [SIGMA]OC pesticide concentrations were also similar with season, consistent with regional and long-range transport (Harner et al. 2004). Contrary to expectation, [SIGMA]PCBs did not show seasonal differences (Halsall et al. 1995), suggesting that regional atmospheric transport may be the source. [SIGMA]N-PAH concentrations were greatest in July, which suggests increased formation of these chemicals resulting from photochemical processes (Atkinson and Arey 1994).

The compounds we analyzed have a wide range of volatilities and varied in their distribution between gas and particulate phases. With the exceptions of [SIGMA]PCDDs/ PCDFs and March [SIGMA]N-PAHs, most compounds were found in gas-phase samples. Not including the PCBs, the five most abundant compounds and congeners in the particulate- and gas-phase samples accounted for 60-95% of the total amount of compound in each class (Table 1). Also, there was no overlap between the most abundant PCBs in the particulate phase and the most abundant PCBs in the gas phases, whereas the most abundant compounds for each of the other chemical classes were similar in both gas and particulate phases. However, the overall concentration of PAHs and OC pesticides were 10 times greater in the gas phase than in the particulate phase, and the reverse was true for PCDDs/PCDFs.

We performed PCA to identify major contributions to variance in the chemical composition of the samples. Data were autoscaled to unit variance, and the analysis included only those compounds/congeners present in both gas and particulate phases. As shown in Figure 2A, the first two components accounted for 87% of the variance for PAHs. Three clusters are evident in the plot for PAHs: all gas-phase samples in the upper left quadrant, which separate from urban particulate phase samples along PC1, and rural particulate phase samples along PC2. Within the cluster of gas-phase samples, July versus March samples separated along PC2. The similarity of urban and rural gas-phase samples relative to their respective particulate-phase samples is likely because of the greater transport distance of gas-phase versus particulate-phase PAHs.

[FIGURE 2 OMITTED]

The concentrations of the gas-phase PAHs anthracene, acenaphthene, fluorene, and phenanthrene distinguished the gas phase from urban and rural particulate phases. Variance in rural particulate-phase samples was explained by concentrations of chrysene, pyrene, and fluoranthene, whereas the variance in urban particulate-phase samples was explained by triphenylene, benzo[a]fluorene, and benzo[b]fluorene.

Samples in the PCA analysis of the PCB data clustered in the same pattern as for PAHs: all gas phase, urban particulate phase, and rural particulate phase (Figure 2B). The first two components accounted for 60% of the variance among samples. The rural particulate-phase July 2000 sample was excluded because of the high-number congeners that were below detection. Variance of the gas-phase samples was explained by trichlorinated and tetrachlorinated congeners (e.g., PCB congeners 16/32, 49, 70/76), whereas variance in urban particulate-phase samples was explained by hexachlorinated and heptachlorinated congeners (e.g., PCB congeners 138, 183, 170).

Biologic activity of air samples in cells in culture. Both gas- and particulate-phase extracts induced significant activation of ER- and AHR-dependent luciferase gene expression. The distinctions in chemical composition between phase, site, and season were not reflected in the results of the CALUX assays, suggesting the aggregate biologic activity of the different congeners in each extract is similar.

As described above, PAHs were the most abundant of the chemical classes analyzed, present at concentrations approximately three to four orders of magnitude greater than those of the potent AHR agonists PCDDs/ PCDFs and one to two orders of magnitude greater than concentrations of the PCBs. These relative amounts are an important factor in the ultimate potency of these extracts. Less than additive, weak agonist interactions are observed with mixtures in in vitro AHR assays, where the concentration of potent agonists is significantly lower than those of more moderate agonists (Safe 1997-1998). Thus, the activity of each extract is influenced by these interactions and reflects the composition of the PAH fraction rather than the PCDD/F and PCB fractions.

AHR reporter cell line. Figure 3 shows the results of extracts in the H1L6.1c1 cell line, grouped by date and site. Results are normalized to protein content in cell extracts and expressed as a percentage of the response in the cell line to [10.sup.-7] M [beta]-NF, which represented the 95th percentile of the [beta]-NF dose--response curve and 100% of the response to [10.sup.-9] M 2,3,7,8-tetrachlorodibenzo-p-dioxin (data not shown).

[FIGURE 3 OMITTED]

All extracts induced luciferase expression in a concentration-dependent manner. In most cases, upper plateaus of response were observed, allowing for comparison of efficacy between extracts. In all cases, gas-phase extracts were less efficacious than the corresponding particulate-phase extracts for the same sampling dates and locations. If the activity of the extracts was driven by the concentration of PAHs, the higher activity of the particulate-phase extracts could be explained by the relatively higher affinity for the AHR of PAHs in this fraction, compared with those in the gas phase (Table 1) (Piskorska-Pliszczynska er al. 1986; Till et al. 1999). Given the relatively large amounts of PAHs in the extracts, we expect this class of contaminants to be at least partly responsible for the AHR-dependent inducing activity observed. Moreover, because of the short duration (4 hr) of the cells' exposure to the mixture, the PAH concentrations would not have been diminished by metabolism.

Ranking the relative potency of the extracts was challenging. The concentration-response curves were not parallel, and the maximum responses of some extracts exceeded the response to a maximally inducing concentration of [10.sup.-7] M [beta]-NF. The reasons for these results are not known; however, others have reported this phenomenon. Inhibition of AHR degradation results in superinduction of AHR-inducible genes (Ma 2002). Alternatively, activation of other signaling pathways may augment AHR function (Seidel et al. 2001) or result in a synergistic increase in AHR-dependent gene expression (Chen and Tukey 1996; Long et al. 1998). The complex mixture that constitutes the gas-and particulate-phase air extracts could be activating any or all of these mechanisms.

The lower efficacy of gas-phase extracts compared with particulate-phase extracts was the only statistically significant observation (unpaired t-test, p = 0.005) between origin of sample and biologic activity. Similar analyses between seasons or locations and efficacy were not statistically significant despite the separation of rural and particulate-phase samples in the PCA. The lack of association between location and efficacy has been reported by others (Binkova et al. 1999).

It was not possible to calculate a true [EC.sub.50] (concentration which produced 50% of the maximum) value for all samples; therefore, to aid comparison of one sample with another, Table 2 shows the concentration of air that elicited 20% and 50% of the response to [10.sup.-7] [beta]-NF in the AHR reporter cell line. Using these values as a measure of relative potency, Table 2 demonstrates that maximum response to a sample can differ for samples with similar relative potency. For example, the urban particulate extract of March 2000 and the urban particulate extract of July 2000 have similar activity at 20% or 50% of the response to [10.sup.-7] [beta]-NF, yet the maximum activity of each sample is quite different. Similarly, the rural particulate extract of July 2000 has similar relative potency to the urban gas-phase extract of July 2001, yet the maximum responses are quite dissimilar. In contrast, the rural gas-phase extract of July 2001 and the urban gas-phase extract of March 2001 are similar in all respects.

These divergent patterns of concentration response are not unexpected. Ligand potency depends not only on the affinity of the receptor for the ligand but also on the ability of the ligand--receptor complex to bind additional transcription factors and elicit a response (Hestermann et al. 2000; Kohn and Melnick 2002). The dose--response curve for each extract is the outcome of the complex interplay of these events. The net effect, that is, the dose-response curve, will depend on the relative agonist--antagonist properties, which are different for each sample in this study (Table 1).

ER reporter cell line. Results of experiments using the extracts in the ER reporter cell line BG1Luc4E2 are shown in Figure 4, where concentration-response data are grouped by site and date. Results were normalized to protein content in cell extracts and expressed as a percentage of the maximum response of [10.sup.-10] M [E.sub.2].

[FIGURE 4 OMITTED]

In contrast to the results obtained in the AHR reporter cell line, the activity of gas-phase extracts, judged by magnitude of induction, frequently exceeded that of particulate-phase extracts in the ER reporter cell line (see, e.g., the gas- vs. particulate-phase extracts for urban March and July 2000, Figure 4A, C). This result is of interest because, as described above, most research examining the activity of organic contaminants of ambient air has focused on particulate-phase extracts. Our results indicate that the gas phase may have activity equal or greater than that of the particulate phase in an ER reporter assay. Table 3 reports the concentration of air at which 50% and 20% of the activity of the reference standard was induced in the ER reporter cell line. As observed for AHR responses, there was no apparent difference in activity between rural and urban sites or between seasons.

Possible sources of estrogenic activity in the ambient air extracts include PAH, PCBs, N-PAHs, and OC pesticides. Various PAHs and PCBs and their metabolites (Fujimoto et al. 2003; Furuta et al. 2004; Pliskova et al. 2005) as well as OC pesticides (Kojima et al. 2004) are reported to be estrogenic. Complicating interpretation of the estrogenic activity, however, is the fact that some PAHs and PCBs and their metabolites also exhibit antiestrogenic activity (Arcaro et al. 1999; Connor et al. 1997; Kramer et al. 1997).

Cellular metabolism in the BG1Luc4E2 cell line includes the cytochrome P450 enzymes, which yield hydroxyl metabolites of PCBs, PAHs, and N-PAHs. Hydroxylated PCBs have been shown to exhibit estrogenic activity in ER-CALUX assays and, in some cases, are more potent than the parent PCBs (Layton et al. 2002; Nesaremam et al. 1996). Hydroxy-PAHs have also been shown to bind and/or activate ER (Charles et al. 2000; Fertuck et al. 2001). Additional classes of estrogenic chemicals not analyzed in our studies but likely to be present in the extracts include phthalate esters, which have been shown to be weak ER agonists (Zacharewski et al. 1998).

Conclusions

To our knowledge, this is the first study to examine the dioxin-like and estrogenic activity of organic extracts of the gas phase of ambient air. Our results not only suggest that mechanistic studies of the health effects of ambient air need to consider both phases as having the potential to induce and/or inhibit AHR and ER signaling pathways but also suggest that the relationship between chemical composition and biologic activity is highly complex. Two of the expected factors driving variation in chemical composition between our samples (phase and location) were mathematically detectable in the PCA. However, the results for urban versus rural location were not discernible in the results of the highly sensitive CALUX bioassays. This may be due to unidentified compounds, nonlinearity between the magnitude of differences in chemical concentration and the response in the CALUX assay, interactions between chemicals and cellular factors, the presence of both agonists and antagonists in the sample, or, more likely, some combination of the above factors.

There is another possibility, however. The fact that an in vivo study comparing the biologic activity (AHR mediated) of organic extracts of [PM.sub.10] along an urban--rural gradient and between seasons also did not find significant locational differences, despite differences in ambient air concentrations of AHR or ER agonists (Binkova et al. 2003), may be because the concentration response of exposure to mixtures of AHR agonists is not sigmoidal due to the impact of weak agonist interactions (Kohn and Melnick 2002). That is to say, the biologic effects of exposure to mixtures of relatively lower concentrations may not be exceeded by those of exposure to mixtures at relatively higher concentrations.

Interestingly, seasonal and locational differences have been observed in some epidemiologic studies comparing different biomarkers and end points with ambient air composition (Dejmek et al. 2000; Perera et al. 2003). The absence of any similar finding in this in vitro study may be due to the high sensitivity of the CALUX assay and its "remoteness" as a receptor assay looking at a specific aspect of one signaling pathway in contrast to the more physiologically complicated in vivo effects examined in epidemiology or other toxicologic studies.

One unanswered question is the relationship between the biologic effects observed in these cell-based assays and inhalation exposures in humans. The average daily intake of air ranges from about 2 [m.sup.3]/day in very young infants to about 24 [m.sup.3]/day in adults (Health Canada 1995). Based on these intake rates, an individual could be exposed to levels at which we observe an effect in vitro and are sufficient to elicit a response in some biologic systems (Bateson and Schwartz 2004; Pope et al. 2004b; Vineis et al. 2004). However, an important consideration is that uptake characteristics are very different between a cell in culture (likely 100%) and inhalation (much less than 100%). Whether or not there is a sustained effect in humans remains to be determined.

Received 13 July 2005; accepted 29 December 2005.

REFERENCES

American Academy of Pediatrics Committee on Environmental Health. 2004. Ambient air pollution: health hazards to children. Pediatrics 114:1699-1707.

Arcaro KF, O'Keefe PW, Yang Y, Clayton W, Gierthy JF. 1999. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133:115-127.

Atkinson R, Arey J. 1994. Atmospheric chemistry of gas-phase polycyclic aromatic-hydrocarbons: formation of atmospheric mutagens. Environ Health Perspect 102(suppl 4):117-126.

Barclay J, Hillis G, Ayres J. 2005. Air pollution and the heart: cardiovascular effects and mechanisms. Toxicol Rev 24:115-123.

Bateson TF, Schwartz J. 2004. Who is sensitive to the effects of particulate air pollution on mortality? A case-crossover analysis of effect modifiers. Epidemiology 15:143-149.

Binkova B, Cerna M, Pastorkova A, Jelinek R, Benes I, Novak J, et al. 2003. Biological activities of organic compounds adsorbed onto ambient air particles: comparison between the cities of Teplice and Prague during the summer and winter seasons 2000-2001. Mulet Res 525:43-59.

Binkova B, Vesely D, Vesela D, Jelinek R, Sram RJ. 1999. Genotoxicity and embryotoxicity of urban air particulate matter collected during winter and summer period in two different districts of the Czech Republic. Mutat Res 440:45-58.

Boffetta P. 2004. Epidemiology of environmental and occupational cancer. Oncogene 23:6392-6403.

Bradford MM 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.

Brook RD, Franklin B, Cascio W, Hang Y, Howard G, Lipsett M, et el. 2004. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109:2655-2671.

Charles GD, Bartels MJ, Zacharewski TR, Gollapudi BB, Freshour NL, Carney EW. 2000. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen-receptor alpha reporter gene assay. Toxicol Sci 55:320-326.

Chen YH, Tukey RH. 1996. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 271:26261-26266.

Clemons JH, Allan LM, Marvin CH, Wu Z, McCarry BE, Bryant DW, et al. 1998. Evidence of estrogen- and TCDD-like activities in crude and fractionated extracts of [PM.sub.10] air particulate material using in vitro gene expression assays. Environ Sci Technol 32:1853-1860.

Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, et al. 1997. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol 145:111-123.

Cordier S, Monfort C, Filippini G, Preston-Martin S, Lubin F, Mueller BA, et al. 2004. Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: the SEARCH International Childhood Brain Tumor Study. Am J Epidemiol 159:1109-1116.

Currado GM, Harrad S. 2000. Factors influencing atmospheric concentrations of polychlorinated biphenyls in Birmingham, U.K. Environ Sci Technol 34:78-82.

Dann T. 1998. Ambient air measurements of polycyclic aromatic hydrocarbons (PAH), polychlorinated dibenzo-p-dioxins (PCDD) and polychlorinated dibenzofurans in Canada (1987-1997). AAQD 97-93. Ottawa, Ontario, Canada: Analysis and Air Quality Division, Environment Canada.

Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. 2000. The impact of polycylic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect 108:1159-1164.

Denison MS, Zhao B, Baston DS, Clark GC, Murata H, Han D-H. 2004. Recombinant cell bioassay systems for the detection and relative quantitation of halogenated dioxins and related chemicals. Talanta 63:1123-1133.

Dimashki M, Lira LH, Harrison RM, Harrad S. 2001. Temporal trends, temperature dependence, and relative reactivity of atmospheric polycyclic aromatic hydrocarbons. Environ Sci Technol 35:2264-2267.

Fertuck KC, Kumar S, Sikka HC, Matthews JB, Zacharewski TR. 2001. Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor. Toxicol Lett 121:167-177.

Fujimoto T, Kitamura S, Sanoh S, Sugihara K, Yoshihara S, Fujimoto N, et al. 2003. Estrogenic activity of an environmental pollutant, 2-nitrofluorene, after metabolic activation by rat liver microsomes. Biochem Biophys Res Commun 303:419-426.

Furuta C, Suzuki AK, Taneda S, Kamata K, Hayashi H, Mori Y, et al. 2004. Estrogenic activities of nitrophenols in diesel exhaust particles. Biol Reprod 70:1527-1533.

Garrison PM, Tullis K, Aarts JM, Brouwer A, Giesy JP, Denison MS. 1996. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol 30:194-203.

Gingrich SE, Diamond ML, Stern GA, McCarry BE. 2001. Atmospherically derived organic surface films along an urban-rural gradient. Environ Sci Technol 25:4031-4037.

Halsall CJ, Lee RGM, Coleman PJ, Burnett V, Harding-Jones P, Jones KC. 1995. PCBs in U.K. air. Environ Sci Technol 29:2368-2376.

Hamers T, van Schaardenburg MD, Felzel EC, Murk AJ, Koeman JH. 2000. The application of reporter gene assays for the determination of the toxic potency of diffuse air pollution. Sci Total Environ 262:159-174.

Han D, Nagy SR, Denison MS. 2004. Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. Biofactors 20:11-22.

Harner T, Shoeib M, Diamond M, Stern G, Rosenberg B. 2004. Using passive air samplers to assess urban-rural trends for persistent organic pollutants. 1. Polychlorinated biphenyls and organochlorine pesticides. Environ Sci Technol 38:4474-4483.

Health Canada. 1995. Investigating Human Exposure to Contaminants in the Environment: A Handbook for Exposure Calculations. Ottawa, Ontario, Canada: Health Canada.

Hestermann EV, Stegeman JJ, Hahn ME. 2000. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol Appl Pharmacol 168:160-172.

Hodge EM, Diamond ML, McCarry BE, Stern GA, Harper PA. 2003. Sticky windows: chemical and biological characteristics of the organic film derived from particulate and gas-phase air contaminants found on an urban impervious surface. Arch Environ Contam Toxicol 44:421-429.

Houtman CJ, Cenijn PH, Hamers T, Lamoree MH, Legler J, Murk AJ, et at. 2004. Toxicological profiling of sediments using in vitro bioassays, with emphasis on endocrine disruption. Environ Toxicol Chem 23:32-40.

Jedrychowski W, Bendkowska I, Flak E, Penar A, Jacek R, Kaim I, et al. 2004. Estimated risk for altered fetal growth resulting from exposure to fine particles during pregnancy: an epidemiologic prospective cohort study in Poland. Environ Health Perspect 112:1398-1402.

Jerrett M, Burnett RT, Ma R, Pope CA III, Krewski D, Newbold KB, et al. 2005 Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology 16:727-736.

Kohn MC, Melnick RL. 2002 Biochemical origins of the non-monotonic receptor-mediated dose-response. J Mol Endocrinol 29:113-123.

Kojima H, Katsura E, Takeuchi S, Niiyama K, Kobayashi K. 2004. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ Health Perspect 112:524-531.

Kramer VJ, Helferich WG, Bergman A, Klasson-Wehler, Giesy JP. 1997. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF-7) cell line. Toxicol Appl Pharmacol 144:363-376.

Layton AC, Sanseverino J, Gregory BW, Easter JP, Sayler GS, Schultz TW. 2002. In vitro estrogen receptor binding of PCBs: measured activity and detection of hydroxylated metabolites in a recombinant yeast assay. Toxicol Appl Pharmacol 180:157-163.

Lee PKH, Brook JR, Dabek-Zlotorzynska E, Mabury SA. 2003. Identification of the major sources contributing to [PM.sub.2.5] observed in Toronto. Environ Sci Technol 37:4831-4840.

Liu S, Krewski D, Shi Y, Chen Y, Burnett RT. 2003. Association between gaseous ambient air pollutants and adverse pregnancy outcomes in Vancouver, Canada. Environ Health Perspect 111:1773-1778.

Lohmann R, Harner T, Thomas GO, Jones KC. 2000. A comparative study of the gas-particle partitioning of PCDD/Fs, PCBs, and PAHs. Environ Sci Technol 34:4943-4951.

Long WP, Pray-Grant M, Tsai JC, Perdew GH. 1998. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol 53:691-700.

Ma Q. 2002. Induction and superinduction of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly(ADP-ribose) polymerase: role of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator transcription activation domains and a labile transcription repressor. Arch Biochem Biophys 404:309-316.

Machala M, Blaha L, Lehmler H J, Pliskova M, Majkova Z, Kapplova P, et al. 2004. Toxicity of hydroxylated and quinoid PCB metabolites: inhibition of gap junctional intercellular communication and activation of aryl hydrocarbon and estrogen receptors in hepatic and mammary cells. Chem Res Toxicol 17:340-347.

Nesaretnam K, Corcoran D, Oils RR, Darbre P. 1996. 3,4,3',4'-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. Mol Endocrinol 10:923-936.

Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Berr D, et al. 2003. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 111:201-205.

Perera FP, Rauh V, Whyatt RM, Tsai WY, Bernert JT, Tu YH, et al. 2004. Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect 112:626-630.

Piskorska-Pliszczynska J, Keys B, Safe S, Newman MS. 1986. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Left 34:67-74.

Pliskova M, Vondracek J, Canton RF, Nera J, Kocan A, Petrik J, et al. 2006. Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum. Environ Hearth Perspect 113:1277-1284.

Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. 2004a. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71-77.

Pope CA III, Hansen ML, Long RW, Nielsen KR, Eatough NL, Wilson WE, et al. 2004b. Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect 112:339-345.

Rogan WJ, Ragan NB. 2003. Evidence of effects of environmental chemicals on the endocrine system in children. Pediatrics 112:247-252.

Rogers JM, Denison MS. 2000. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. In Vitro Mol Toxicol 13:67-82.

Rogge WF, Hildemann LM, Mazurek MA, Cass GR, Simoneit BRT. 1993. Quantification of urban organic aerosols at a molecular level--identification, abundance and seasonal variation. Atmos Environ A 27:1309-1330.

Safe S. 1997-1998. Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratog Carcinog Mutagen 17:289-304.

Seidel SD, Winters GM, Rogers W J, Ziccardi MH, Li V, Keser B, et al. 2001 Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 15:187-196.

Takeda K, Tsukue N, Yoshida S. 2004. Endocrine-disrupting activity of chemicals in diesel exhaust and diesel exhaust particles. Environ Sci 11:33-45.

Till M, Riebniger D, Schmitz H-J, Schrenk D. 1999. Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures. Chem Biol Interact 117:135-150.

Vineis P, Forastiere F, Hoek G, Lipsett M. 2004. Outdoor air pollution and lung cancer: recent epidemiologic evidence. Int J Cancer 111:647-852.

Vinggaard AM, Hnida C, Larsen JC. 2000. Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro. Toxicology 145:173-183.

Vondracek J, Chramostova K, Pliskova M, Blaha L, Brack W, Kozubik A, et al. 2004. Induction of aryl hydrocarbon receptor-mediated and estrogen receptor-mediated activities, and modulation of cell proliferation by dinaphthofurans. Environ Toxicol Chem 23:2214-2220.

Wang J, Wu W, Henkelmann B, You L, Kettrup A, Schramm K-W. 2003. Presence of estrogenic activity from emission of fossil fuel combustion as detected by a recombinant yeast bioassay. Atmos Environ 37:3225-3235.

Watanabe N, Kurita M. 2001. The masculinization of the fetus during pregnancy due to inhalation of diesel exhaust. Environ Health Perspect 109:111-119.

Windal I, Denison MS, Birnbaum LS, Van Wouwe N, Baeyens W, Goeyens L. 2005 Chemically activated luciferase gene expression (CALUX) cell bioassay analysis for the estimation of dioxin-like activity: critical parameters of the CALUX procedure that impact assay results. Environ Sci Technol 39:7357-7384.

Zacharewski TR, Meek MD, Clemons JH, Wu ZF, Fielden MR, Matthews JB. 1998. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol Sci 46:282-293.

Gaff P. Klein, (1) Erin M. Hodge, (2) Miriam L. Diamond, (2) Amelia Yip, (1) Tom Dann, (3) Gary Stern, (4) Michael S. Denison, (5) and Patricia A. Harper (1,6)

(1) Department of Pharmacology, and (2) Department of Geography, Centre for Urban Health Initiatives, University of Toronto, Toronto, Ontario, Canada; (3) Analysis and Air Quality Division, Environment Canada, Ottawa, Ontario, Canada; (4) Freshwater Institute, University of Manitoba, Winnipeg, Manitoba, Canada; (5) Department of Environmental Toxicology, University of California, Davis, California, USA; (6) program in Developmental Biology, Hospital for Sick Children, Toronto, Ontario, Canada

Address correspondence to P.A. Harper, Program in Developmental Biology, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada M5G 1X8. Telephone: [phone]. Fax: [phone]. E-mail: [e-mail]

We thank C. Butt (University of Toronto) and F. Wong (Meteorological Service of Canada).

This research was supported by the Toxic Substances Research Initiative of Health Canada and Environment Canada (M.L.D., T.D., P.A.H, G.S.), Premier's Research Excellence Award (M.L.D.), Canadian Institutes of Health Research (P.A.H.), U.S. Environmental Protection Agency STAR Grant (RS82867601, M.S.D.), and the National Institute of Environmental Health Sciences, U.S. National Institutes of Health (ES04699, M.S.D.).

The authors declare they have no competing financial interests.

Table 1. Mean percentage of sample composed of the five most abundant
compounds listed in descending order.

Compounds                Gas phase               Particulate phase

PAHs             95% of total:               60% of total:
                 phenanthrene,               benzo[g,h,i]perylene,
                 fluoranthene, pyrene,       benzo[b]fluoranthene,
                 fluorene, anthracene,       fluoranthene, pyrene,
                 2-methyl fluorine           indenol[1,2,3-c,d]pyrene

PCBs             13% of total: PCB           8% of total: PCB
                 congeners 52, 95, 31,       congeners 138, 153, 8/5,
                 18, and 101                 180, 149

N-PAHs           99% of total:               100% of total:
                 9-nitroanthracene,          9-nitroanthracene,
                 2-nitrofluoranthene,        2-nitrofluoranthene,
                 1-nitropyrene,              1-nitropyrene,
                 9-nitrophenanthrene,        7-nitrobenz[a]anthracene,
                 7-nitrobenz[a]anthracene    6-nitrobenzo[a]pyrene

PCDDs/PCDFs      88% of total: 2,3,7,8,-     94% of total: OCDD,
                 tetraCDF, octaCDD, 1,2,3,   1,2,3,4,6,7,8-heptaCDD,
                 4,6,7,8,-hepta-CDD, 1,2,    1,2,3,4,6,7,8-heptaCDF,
                 3,4,6,7,8,-heptaCDF,        octaCDF
                 2,3,4,7,8,-pentaCDF,
                 1,2,3,4,7,8-hexaCDF

OC pesticides    82% of total: endosulfan,   82% of total: endosulfan,
                 7-HCH, p,p-DOE, dieldrin,   p,p'-DDT, p,p'-DDE,
                 a-HCH                       dieldrin, [gamma]-HCH

Abbreviations: CDD, chlorinated dibenzodioxin; CDF, chlorinated
dibenzofuran; DDE, dichlorodiphenyldichloroethylene; HCH,
hexachlorcyclohexane.

Table 2. Apparent potency of samples in AHR reporter gene assay
at different induction levels and maximum induction, in descending
order.

                                  20% of
Sample              [10.sup.-7] M [beta]-NF ([m.sup.3])

urb part Mar 00                    0.01
urb part Jul 01                    0.02
urb part Jul 00                    0.02
urb gas Mar 00                     0.03
rur part Jul 01                    0.04
urb part Mar 01                    0.04
urb gas Jul 01                     0.06
rur part Jul 00                    0.09
urb gas Jul 00                     0.19
rur gas Jul 00                     0.41
rur gas Jul 01                     0.9
urb gas Mar 01                     1.02

                                  50% of
Sample              [10.sup.-7] M [beta]-NF ([m.sup.3])

urb part Mar 00                     0.04
urb part Jul 01                     0.08
urb part Jul 00                     0.09
rur part Jul 01                     0.14
urb part Mar 01                     0.18
rur Jul part 00                     0.28
urb gas Jul 01                      0.58
urb gas Mar 00                      0.66
rur gas Jul 00                      5.00
urb gas Jul 00                      6.32
rur gas Jul 01                    -- (a)
urb gas Mar 01                    -- (a)

                                 Efficacy
Sample                       (% of [beta]-NF)

urb part Mar 00                 No plateau
rur part Jul 00                 No plateau
rur part Jul 01                     129
urb part Jul 00                     110
urb part Jul 01                      92
urb part Mar 01                      87
urb gas Jul 01                       60
urb gas Mar 00                       58
rur gas Jul 00                       58
urb gas Jul 00                       52
urb gas Mar 01                       48
rur gas Jul 01                       33

Abbreviations: part, particulate; rur, rural sample; urb,
urban sample.

(a) Sample did not elicit 50% of the activity of [10.sup.-7] M
[beta]-NF.

Table 3. Apparent potency of samples in ER reporter gene assay at
different induction levels, in descending order.

                                  20% of
Sample              [10.sup.-10] estradiol ([m.sup.3])

urb gas Jul 00                     0.39
urb gas Mar 00                     0.62
urb gas Jul 01                     1.90
rur gas Jul 01                     2.27
rur part Jul 00                    2.32
urb gas Mar 01                     2.90
rur gas Jul 00                     3.97
urb part Mar 00                    4.58
urb part Mar 01                    5.28
urb part Jul 00                    7.26
rur part Jul 01                   12.25
urb part Jul 01                   18.47

                                  50% of
Sample              [10.sup.-10] estradiol ([m.sup.3])

urb gas Jul 00                      1.26
urb gas Mar 00                      2.25
rur gas Jul 01                      6.23
rur part Jul 00                     6.92
urb gas Jul 01                      7.65
urb gas Mar 01                      9.48
urb part Mar 00                    11.23
rur gas Jul 00                     12.45
urb part Mar 01                    12.50
rur part Jul 01                   -- (a)
urb part Jul 00                   -- (a)
urb part Jul 01                   -- (a)

Abbreviations: part, particulate; rur, rural sample; urb,
urban sample. (a) Sample did not elicit 50% of the activity
of [10.sup.-10] estradiol.